Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,154 | -3,127 | -8,294 | -5,938 | -4,084 |
| Depreciation Amortization | 392 | 196 | 759 | 568 | 379 |
| Accounts payable and accrued liabilities | 22 | 253 | 706 | 164 | 380 |
| Other Working Capital | -136 | 276 | 997 | 361 | 695 |
| Other Operating Activity | 91 | -193 | -483 | 10 | -261 |
| Operating Cash Flow | $-4,786 | $-2,595 | $-6,316 | $-4,834 | $-2,891 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47 | -47 | -157 | -58 | -14 |
| Investing Cash Flow | $-47 | $-47 | $-157 | $-58 | $-14 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,993 | 1,710 | 3,120 | N/A | N/A |
| Financing Cash Flow | $3,993 | $1,710 | $3,120 | $N/A | $N/A |
| Beginning Cash Position | 4,798 | 4,798 | 8,150 | 8,150 | 8,150 |
| End Cash Position | 3,958 | 3,866 | 4,798 | 3,257 | 5,245 |
| Net Cash Flow | $-840 | $-932 | $-3,352 | $-4,893 | $-2,904 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,786 | -2,595 | -6,316 | -4,834 | -2,891 |
| Capital Expenditure | -47 | -47 | -157 | -58 | -14 |
| Free Cash Flow | -4,833 | -2,642 | -6,472 | -4,893 | -2,905 |